SCHEMBL933844

SCHEMBL933844

CCCOS(=O)(=O)OC(CC)OC

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL28238055 0.75 CA1 (0.43) CA1CA2
SCHEMBL9980710 0.75 CA1 (0.43) CA1CA2
SCHEMBL9980923 0.74 CA1 (0.46) CA1CA2
SCHEMBL29875489 0.72 CA1 (0.44) CA1CA2
SCHEMBL301444 0.72 CA1 (0.60) CA1CA2
SCHEMBL17456501 0.72
SCHEMBL17456498 0.72
SCHEMBL439942 0.71
SCHEMBL2460222 0.71
SCHEMBL31083284 0.70 CA1 (0.57) CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120264907-A1 PREPARATION OF POLYAMIDES INVISTA NORTH AMERICA S.A.R.L. (US) 2012-10-18 US claimed
EP-2451863-A1 PREPARATION OF POLYAMIDES Invista Technologies S.A R.L. (CH) 2012-05-16 EP claimed
WO-2011004138-A1 PREPARATION OF POLYAMIDES INVISTA TECHNOLOGIES S.A.R.L. (CH) 2011-01-13 WO claimed
EP-2640686-B1 NITROUS OXIDE-CONTAINING IONIC LIQUIDS AS CHEMICAL REAGENTS INVISTA TECH SARL (CH) 2014-12-24 EP disclosed
EP-2640686-A2 NITROUS OXIDE-CONTAINING IONIC LIQUIDS AS CHEMICAL REAGENTS Invista Technologies S.A R.L. (CH) 2013-09-25 EP disclosed
EP-2456807-B1 SYNTHESIS METHOD USING IONIC LIQUIDS INVISTA TECH SARL (CH) 2013-07-17 EP disclosed
EP-2456807-A2 SYNTHESIS METHOD USING IONIC LIQUIDS Invista Technologies S.A R.L. (CH) 2012-05-30 EP disclosed
WO-2012066296-A2 NITROUS OXIDE-CONTAINING IONIC LIQUIDS AS CHEMICAL REAGENTS INVISTA TECHNOLOGIES S.A.R. L. (CH) 2012-05-24 WO disclosed
EP-2451863-A1 PREPARATION OF POLYAMIDES Invista Technologies S.A R.L. (CH) 2012-05-16 EP disclosed
WO-2011010116-A2 SYNTHESIS METHOD USING IONIC LIQUIDS INVISTA TECHNOLOGIES S.À.R.L. (CH) 2011-01-27 WO disclosed
WO-2011004138-A1 PREPARATION OF POLYAMIDES INVISTA TECHNOLOGIES S.A.R.L. (CH) 2011-01-13 WO disclosed
EP-2051788-A1 EXTRACTION PROCESS USING AN IONIC LIQUID Invista Technologies S.à.r.l. (CH) 2009-04-29 EP disclosed
US-7442841-B2 Extraction process INVISTA NORTH AMERICA S.A R.L. (US) 2008-10-28 US disclosed
US-20080051609-A1 EXTRACTION PROCESS INVISTA NORTH AMERICA S.A.R.L. (US) 2008-02-28 US disclosed
WO-2008022233-A1 EXTRACTION PROCESS USING AN IONIC LIQUID INVISTA TECHNOLOGIES S.A.R.L. (CH) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051609-A1 EXTRACTION PROCESS ADH1C, ADH1A, ADH5 CA1 2974/4885CA2 4188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.